Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Julia Lichtnekert

An Orally Active Chemokine Receptor CCR2 Antagonist Prevents Glomerulosclerosis and Renal Failure in Type 2 Diabetes

Kidney International

English

Reducing mTOR Augments Parietal Epithelial Cell Density in a Model of Acute Podocyte Depletion and in Aged Kidneys

American Journal of Physiology - Renal Physiology

English

Related publications

Novel, Orally Bioavailable G-Aminoamide CC Chemokine Receptor 2 (CCR2) Antagonists

English

Functional Inhibition of Chemokine Receptor CCR2 by Dicer-Substrate-siRNA Prevents Pain Development

Molecular Medicine

Molecular Neuroscience

English

SM16, an Orally Active TGF- Type I Receptor Inhibitor Prevents Myofibroblast Induction and Vascular Fibrosis in the Rat Carotid Injury Model

Arteriosclerosis, Thrombosis, and Vascular Biology

Cardiovascular Medicine

English

Cerebral Microvascular Disease Predicts Renal Failure in Type 2 Diabetes

Journal of the American Society of Nephrology : JASN

English

Alkylsulfone-Containing Trisubstituted Cyclohexanes as Potent and Bioavailable Chemokine Receptor 2 (CCR2) Antagonists

Bioorganic and Medicinal Chemistry Letters

Organic Chemistry

Molecular Medicine

Molecular Biology

Clinical Biochemistry

Pharmaceutical Science

English

Discovery of an Orally-Active Nonsteroidal Androgen Receptor Pure Antagonist and the Structure–Activity Relationships of Its Derivatives

Chemical and Pharmaceutical Bulletin

English

Factors Affecting Progression of Renal Failure in Patients With Type 2 Diabetes

Internal Medicine

Specialized Nursing

English

Chemokine Receptor Genotype Is Associated With Diabetic Nephropathy in Japanese With Type 2 Diabetes

Internal Medicine

English

Impaired Neuropathic Pain Responses in Mice Lacking the Chemokine Receptor CCR2

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English